The Immunology Database and Analysis Portal (ImmPort) has been developed under the Bioinformatics Integration Support Contract (BISC) Phase II by the Northrop Grumman Information Technology Health Solutions team for the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Division of Allergy, Immunology, and Transplantation (DAIT).
ImmPort is a partnership between researchers at the University of California-San Francisco, Stanford University, the University of Buffalo, the Technion - Israel Institute of Technology, and Northrop Grumman.
The goals of the ImmPort project are to:
The ImmPort project provides advanced information technology support in the archiving and exchange of scientific data for the diverse community of life science researchers supported by NIAID/DAIT and serves as a long-term, sustainable archive of research and clinical data. The core component of ImmPort is an extensive data warehouse containing experimental data and metadata describing the purpose of the study and the methods of data generation. The functionality of ImmPort will be expanded continuously over the life of the BISC project to accommodate the needs of expanding research communities. The shared research and clinical data, as well as the analytical tools in ImmPort are available to any researcher after registration.
Private data and pre-release data are stored in private workspaces of investigators at the ImmPort site located at NIAID, http://immport.niaid.nih.gov. Once shared, studies may be searched at the Open ImmPort site: www.immport.org.